INTERPACE BIOSCIENCES, INC. Annual Return On Equity in % from 2012 to 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Interpace Biosciences, Inc. quarterly/annual Return On Equity history and growth rate from 2012 to 2024.
  • Interpace Biosciences, Inc. Return On Equity for the quarter ending December 31, 2024 was -16.8 %, a 386% decline year-over-year.
  • Interpace Biosciences, Inc. annual Return On Equity for 2024 was -16.8 %, a 386% decline from 2023.
  • Interpace Biosciences, Inc. annual Return On Equity for 2023 was -3.45 %, a 108% decline from 2022.
  • Interpace Biosciences, Inc. annual Return On Equity for 2022 was 41.4 %, a 3.81% increase from 2021.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2024 -16.8 -13.3 -386% Jan 1, 2024 Dec 31, 2024
2023 -3.45 -44.9 -108% Jan 1, 2023 Dec 31, 2023
2022 41.4 +1.52 +3.81% Jan 1, 2022 Dec 31, 2022
2021 39.9 -95.9 -70.6% Jan 1, 2021 Dec 31, 2021
2020 136 +457 Jan 1, 2020 Dec 31, 2020
2019 -322 -257 -396% Jan 1, 2019 Dec 31, 2019
2018 -64.9 -137 -190% Jan 1, 2018 Dec 31, 2018
2017 72 -878 -92.4% Jan 1, 2017 Dec 31, 2017
2016 950 +1.1K Jan 1, 2016 Dec 31, 2016
2015 -147 -83.7 -132% Jan 1, 2015 Dec 31, 2015
2014 -63.6 -51 -402% Jan 1, 2014 Dec 31, 2014
2013 -12.7 +35 +73.4% Jan 1, 2013 Dec 31, 2013
2012 -47.7 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.